megalin-STRIKERS
Judo Bio Launches with $100M to Pioneer Kidney-Targeted siRNA Therapies
Judo Bio, siRNA therapies, kidney diseases, oligonucleotide medicines, STRIKE platform, megalin-STRIKERS, renal diseases, genetic medicines.
Actionable Insights Powered by AI
Judo Bio, siRNA therapies, kidney diseases, oligonucleotide medicines, STRIKE platform, megalin-STRIKERS, renal diseases, genetic medicines.